AU7699396A - Use of 2-aminobenzothiazoles for treating parkinson's disease and parkinsonian syndromes - Google Patents

Use of 2-aminobenzothiazoles for treating parkinson's disease and parkinsonian syndromes

Info

Publication number
AU7699396A
AU7699396A AU76993/96A AU7699396A AU7699396A AU 7699396 A AU7699396 A AU 7699396A AU 76993/96 A AU76993/96 A AU 76993/96A AU 7699396 A AU7699396 A AU 7699396A AU 7699396 A AU7699396 A AU 7699396A
Authority
AU
Australia
Prior art keywords
aminobenzothiazoles
disease
treating parkinson
parkinsonian syndromes
parkinsonian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76993/96A
Other languages
English (en)
Inventor
Alain Boireau
Marie-Christine Dubroeucq
Assunta Imperato
Patrick Jimonet
Serge Mignani
John Randle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Publication of AU7699396A publication Critical patent/AU7699396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76993/96A 1995-12-01 1996-11-26 Use of 2-aminobenzothiazoles for treating parkinson's disease and parkinsonian syndromes Abandoned AU7699396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9514239A FR2741803A1 (fr) 1995-12-01 1995-12-01 Application de 2-aminobenzothiazoles dans le traitement de la maladie de parkinson et des syndromes parkinsoniens
FR9514239 1995-12-01
PCT/FR1996/001866 WO1997020557A1 (fr) 1995-12-01 1996-11-26 Application de 2-aminobenzothiazoles dans le traitement de la maladie de parkinson et des syndromes parkinsoniens

Publications (1)

Publication Number Publication Date
AU7699396A true AU7699396A (en) 1997-06-27

Family

ID=9485068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76993/96A Abandoned AU7699396A (en) 1995-12-01 1996-11-26 Use of 2-aminobenzothiazoles for treating parkinson's disease and parkinsonian syndromes

Country Status (6)

Country Link
EP (1) EP0866703A1 (fr)
JP (1) JP2000505059A (fr)
AU (1) AU7699396A (fr)
FR (1) FR2741803A1 (fr)
WO (1) WO1997020557A1 (fr)
ZA (1) ZA969971B (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826860A (en) * 1987-03-16 1989-05-02 Warner-Lambert Company Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
ES2043070T3 (es) * 1988-12-15 1993-12-16 Rhone Poulenc Sante Procedimiento para la preparacion de derivados de la benzotiazolamina-2.

Also Published As

Publication number Publication date
EP0866703A1 (fr) 1998-09-30
JP2000505059A (ja) 2000-04-25
ZA969971B (en) 1997-06-18
WO1997020557A1 (fr) 1997-06-12
FR2741803A1 (fr) 1997-06-06

Similar Documents

Publication Publication Date Title
AU1402895A (en) Use of pla2 inhibitors as treatment for alzheimer's disease
GR3023817T3 (en) BIS-STAUROSPORINE AND K-252a DERIVATIVES.
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
AU6965996A (en) Method and apparatus for maintaining the position of body parts
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU7623096A (en) Use of epinastine in the treatment of pain
AU1833699A (en) Device and method for treating parkinson's disease
EP0331620A3 (en) Agent for the treatment of parkinson's disease
AU7397094A (en) Prevention and treatment of alzheimer's disease
AU3279395A (en) Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
EP1011644A4 (fr) Methodes et appareil de traitement de la maladie de parkinson
AU1578295A (en) Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
BR9607032A (pt) Aparelho para suportar uma parte do corpo de uma pessoa e processo de ajustar as pressões aplicadas no aparelho
AU4312593A (en) Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
AU3717995A (en) Mutant activated gsalpha* and adenylyl cyclase 2 for use as therapeutic agents
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
AU4517096A (en) The treatment of autoimmune disease using 2-amino purine derivatives
AU6401696A (en) Early onset alzheimer's disease gene and gene products
AU7699396A (en) Use of 2-aminobenzothiazoles for treating parkinson's disease and parkinsonian syndromes
AU7622798A (en) Application of thalidomide to the treatment of Parkinson's disease and Parkisonian syndromes
AU6406098A (en) Use of minalcipran and its derivatives for preparing a medicine for treating certain psychiatric diseases
AU1807592A (en) New combination preparation for treatment of parkinson's disease
AU7699496A (en) Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders